nuclear enzyme activated by DNA strand breaks induced by 570 006 and 2 Department of Applied Zoology, Jnanasahyadri, Kuvempu University, B.R. alkylating agents or X-rays (Cleaver et al., 1983; Chatterjee and Berger, 1994; Kleczkowska and Althaus, 1996) . PARP The molecular mechanism of the adaptive response or upon activation catalyses of poly(ADP-ribosyl)ation of the inducible DNA repair process has not been clearly various nuclear proteins and also that of PARP by utilizing demonstrated in eukaryotic systems. results are discussed in this paper. These results are discussed with reference to the enhancement of the adaptive response by nicotinamide in mouse Materials and methods bone marrow cells.
Introduction

Chemicals
The adaptive DNA repair process or inducible DNA repair
The monofunctional alkylating agent, EMS (CAS-62-50-0) and the nicotinpathway is a novel type of repair pathway among the several amide (N, CAS-98-92-0) were obtained from Sigma Chemical Company repair mechanisms known to date, wherein the cells pre- (USA) . The EMS and nicotinamide were dissolved in 0.7% NaCl and distilled water, respectively, to obtain required concentrations. 0.5 ml of the fixed exposed to a low dose of a clastogen are more resistant to the concentration was injected intraperitoneally. Freshly prepared chemical soludamaging effects of a challenge dose of the same agent.
tions were used. Two doses of EMS, 80 (conditioning, L) and 240 mg/kg This phenomenon, termed 'the adaptive response', was first body weight (challenge, H) were selected from the earlier experiments (Riaz demonstrated by Samson and Cairns (1977) in Escherichia Mahmood and Vasudev, 1993) . Nicotinamide concentrations ranging from 5 to 50 mM/kg body weight were employed in the initial experiments to coli. Extensive reports are available on the existence of the evaluate the toxicity (Table I ). The results indicated that the lowest dose of adaptive response in prokaryotes and in in vitro eukaryotes 5 mM produces least toxicity when administered with combined treatments using physical agents like X-rays, γ-rays (Olivieri et al., 1984;  and at the same time the mitotic index was equivalent to controls when Shadely and Wolff, 1987; Sankaranarayanan et al., 1989;  compared with higher doses. Hence, the dose of 5 mM/kg body weight Liazen Zhang, 1995; Ikushima et al., 1996; Wolff, 1996;  was selected. Lankinen and Vilpo, 1997; Nikolai et al., 1998) 
and chemicals
Treatment schedule such as, N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG),
EMS combined treatment
This was again selected from the previous experiments of Riaz Mahmood and methylnitrosourea (MNU), ethylnitrosourea (ENU) and mito- Vasudev (1993) , who have shown that the 8 h time lag (TL) between the mycin C (Samson and Schwartz, 1980; Kaina, 1982; conditioning and challenging treatment offered maximum protection with and Bosi, 1990; Mudrigal-Bujaidar et al., 1994; Kleczkowska respect to the chromosomal aberrations in mouse bone marrow cells; thus and Althaus, 1996; Nikolova and Huttner, 1996) .The same exhibiting a peak of repair activity compared with other TLs. Therefore, the 8 h TL was selected for the present studies.
phenomenon was reported in the cells of higher plants by using alkylating and non-alkylating agents (Rieger et al., Nicotinamide inter-treatment 1982 Baranczewski et al., 1997) . We demonstrated the Nicotinamide inter-treatment was made during the period between the conditioning and challenging doses. As the 8 h TL was found to be at peak action existence of adaptive response in grasshopper and mouse or repair (Riaz Mahmood and Vasudev, 1993) , this TL was used. Nicotinamide in vivo Vasudev, 1990-1993; was injected 2 or 4 h after the conditioning dose. Then after 6 or 4 h they Mahmood et al., 1996; Vasudev et al., 1997) and also in vitro were challenged with the challenge dose of EMS.
in human lymphocytes (Harish et al., 1998) . Although there Nicotinamide pretreatment are considerable data on the adaptive response, the molecular In this treatment schedule, animals received nicotinamide, 4 or 6 h prior to mechanism remains unclear. Different repair enzymes are the conditioning dose of EMS and 8 h later they were challenged with the EMS high dose. implicated in this repair pathway. Poly(ADP-ribose) poly- 3 To whom correspondence should be addressed. 
Data of two independent experiments; 600 cells were scored per experiment; h, hours, BЈ, chromatid break; BЉ, isochromatid break; RBЈ, chromatid exchanges; RBЈBЈЈ, triradials; ID, intrachromatid deletion; a Significant compared with controls (P Ͻ 0.05). b Significant compared with challenge dose (P Ͻ 0.05). c Significant compared with combined treatment (P Ͻ 0.05).
Nicotinamide post-treatment dry technique (Evans et al., 1964) . In brief, the femur bones were dissected out and cleaned. Then the bone marrow was flushed into 0.56% potassium Nicotinamide was given 6, 12 or 18 h after the combined treatment of EMS.
chloride (hypotonic) solution with the help of 26 gauge needle attached to a Slide preparation and chromosome analysis 2 ml syringe. The suspension was incubated at 37°C for 30 min. After Animals were killed by cervical dislocation at 24, 48 or 72 h recovery times incubation, the cell suspension was centrifuged at 800 r.p.m. for 7 min. The (RTs) after the challenge dose. 0.5 ml of the 0.05% colchicine was injected supernatant was discarded. Then the fixative, methanol/acetic acid (3:1 v/v), into the animals 90 min prior to sacrifice. After the animals had been killed, was added to the pellet and mixed well. This suspension was centrifuged after 10 min. After fixing the cells three times, the pellet was resuspended in the bone marrow was processed and slides were prepared by the routine air- (Riaz Vasudev, 1990-1993; Riaz Mahmood et al., 1996; Vasudev et al., 1997) . The results of inter-and Results pretreatments of nicotinamide have revealed a significant reduction in the frequency of chromosomal aberrations (P Ͻ The data obtained from a minimum of two independent 0.05) compared with the combined or challenge dose (Tables  experiments are given in Tables II-IV and their mean values II-IV and Figures 1 and 2 ). Nicotinamide alone induced are also incorporated. There were no significant variations in insignificant chromosomal aberration frequencies as compared the frequencies of chromosomal aberrations between the two with controls. On the other hand, in the post-treatment at all experiments (P Ͼ 0.05). Chromosomal aberrations were time pauses, the aberration frequency was significantly reduced induced after conditioning, challenging and combined treat-(P Ͻ 0.05) compared with the challenge dose, the frequency ments of EMS after 24, 48 and 72 h RTs and their frequencies of aberrations was almost equal to the combined treatment at are presented in Tables II-IV . These results show that the EMS the 6 h time-pause. However, it is interesting to note that, at induced a very high frequency of chromatid breaks, exchanges, 12 or 18 h post-treatment, the reduction of chromosomal intrachromatid deletions and minutes at all RTs. The minutes aberrations is significant compared with the combined treatare of chromatid-type not chromosomal-type, i.e. double ment (Tables II-IV and Figure 3) . Similarly, in accordance with minutes. The conditioning dose induced 13-15% aberrations, the reduction of the frequency of chromosomal aberrations, the whereas the challenging dose produced 70-75% aberrations, aberrant cell frequency was also reduced in the combined which is significantly higher compared with controls (Tables  II-IV and Figures 1-3) . The combined treatment (conditioningand other treatment schedules (Tables II-IV) . Mitotic indices (Table V) . the present investigations were undertaken using nicotinamide as an inhibitor of PARP. The results of inter-treatment of nicotinamide (L-2 h-N-6 h-H and L-4 h-N-4 h-H) have revealed that the frequency of chromosomal aberrations has been significantly reduced compared with the combined treatment (Tables II-IV and Figure 1 ; P Ͻ 0.05). This indicates that the nicotinamide potentiates the EMS-induced adaptive response in the mouse bone marrow cells. In the posttreatment, as there is a significant reduction in the frequency of chromosomal aberrations at 12 or 18 h, it is proposed that nicotinamide protects the genetic system after 6 h of challenge treatment. This long duration in the activity of nicotinamide is because of the fact that the high dose of the mutagen might have disturbed the genetic machinery to release the required enzyme(s) and to repair the damage. The pre-and intertreatment results show similarities in the way of reduction of DNA repair in in vitro cells (Ding et al., 1992) . In support of L-8 h-H-18 h-N 7.3 7.1 6.6 these observations, Melissa et al. (1998) have demonstrated Data derived from 5000 cells scored for each treatment.
that there is a synthesis of poly(ADP-ribose) polymers in PARP -/-cells in a damage-dependent manner. This indicates the involvement of different mechanism(s) for the synthesis mainly the chromatid-type of aberrations produced in the bone marrow cells of the mouse. This is in line with earlier of poly(ADP-ribose) polymers in DNA repair. Caria et al. (1997) have demonstrated that there is an alternative repair observations, wherein the mutagenic and clastogenic effects of EMS were observed (Riaz Mahmood and Vasudev, 1990- pathway in the absence of PARP in in vitro human lymphocytes of the Down syndromes. Contrary to these, inhibitors of PARP 1994; Riaz Mahmood et al., 1996; compare with Vogel and Natarajan, 1982) . Present results also point to the presence of increased the incidence of chromosomal aberrations, SCEs (Wiencke et al., 1986; Catena et al., 1994; Kupper et al. , adaptive response induced by EMS (Tables II-IV and Figures  1-3) , which is consistent with the previous reports on adaptive Schreiber et al., 1995) and suppressed the adaptive response when applied during 2 h after the adaptive treatment response induced by chemicals (Samson and Schwartz, 1980; Kaina, 1982; Olivieri and Bosi, 1990; Riaz Mahmood (Wiencke et al., 1986; Shadley and Wolff, 1987) . PARP involvement in the DNA repair process was also reported in and Vasudev, 1990 Vasudev, -1993 Mudrigal-Bujaidar et al., 1994; Kleczkowska and Althaus, 1996; Nikolova and Huttner, 1996;  various cell types (Park and Kim, 1983; Cleaver et al., 1985; Cleaver and Morgan, 1991; Shall, 1994) . Riaz Mahmood et al., 1996; Vasudev et al., 1997; Harish et al., 1998 Harish et al., , 2000 . Results obtained in the present investigations with
In the present studies, cytotoxicity of chemicals has been analyzed using the mitotic index of treated cells. The results 8 h TL between the conditioning and challenging were similar to the earlier observations of Riaz Mahmood and Vasudev of the mitotic index have shown that nicotinamide has no effect on the cell cycle and in turn enhance the mitotic divisions (1993). Wiencke (1987) who worked on the influence of PARP (Table V) . This may be due to the action of nicotinamide in preserving NAD ϩ levels in the cells. In line with this, the inhibitors on the adaptive response in in vitro human lymphocytes proposed that 'ADPRT, itself and not other metabolic nicotinamide and other inhibitors of PARP are reported to prevent depletion of NAD ϩ (de Murcia and Menisser de processes affected by inhibitors of this enzyme, plays an important role in the adaptive response'. Keeping this in mind, Murcia, 1994; Lindahl et al., 1995) and protect the cells from 1994, 1996; Cosi and Marien, 1998; Chatterjee et al., 1999;  prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Kolb and Burkart, 1999) .
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In conclusion, our results have clearly indicated the 
